8 weeks (8 vials): 24 mL 3 10 mL bottles 12 weeks (12 vials): 36 mL 4 10 mL bottles 16 weeks (16 vials): 48 mL 5 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each day
Santello, Mirko, Paola Bezzi, and Andrea Volterra
SYNCHRONIZE-CVOT is an event driven cardiovascular outcome trial enrolling patients with preobesity or obesity with cardiovascular disease, chronic kidney disease, or risk factors for cardiovascular disease
If the safety and modest efficacy data from the published trials translate to our patient population, it would give us a tool that acts directly on fat cell metabolism rather than appetite, with a side effect profile that appears extremely well-tolerated
[DOI] [PMC free article] [PubMed] [Google Scholar] 209.Mattmiller S.A., Carlson B.A., Sordillo L.M
Here are its limitations: Mostly animal data